UD

Urmila Devi

Director Director DIN 03613513
DIN 03613513 First appointment Oct 2011 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2011
Shareholding value Locked Premium profile

About Urmila Devi

Urmila Devi has 14 years in corporate governance. Formerly with 1 company, such as Kras Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03613513
Primary Designation Director
First Appointment 07 Oct 2011
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Kras Pharmaceuticals Private Limited U00304BR1985PTC002219
Director 07 Oct 2011 1985 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kras Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Urmila Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmila Devi

Urmila Devi has 14 years in corporate governance. Formerly with 1 company, such as Kras Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Urmila Devi is associated with 0 companies as a director.

Urmila Devi has expertise in General Business.

Urmila Devi has 14 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available